Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anthrax: a disease in waiting?

L Doganay1, L Dognany, P D Welsby

  • 1Department of Internal Medicine, Dokuz Eylul University, Tip Fakultesi ic Hastaliklari AD, Inciralti, Izmir 35340, Turkey. levent.doganay@deu.edu.tr

Postgraduate Medical Journal
|November 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors Affecting Recurrence and Survival After Liver Transplantation for Hepatocellular Carcinoma.

Transplantation proceedings·2018
Same author

A wake-up call?

The journal of the Royal College of Physicians of Edinburgh·2017
Same author

HIV infection in Muirhouse

The journal of the Royal College of Physicians of Edinburgh·2017
Same author

Rhino-Orbita-Maxillary Mucormycosis After Liver Transplantation: A Case Report.

Transplantation proceedings·2016
Same author

Large Cell Neuroendocrine Carcinoma of the Ovary and Its Skin Metastases: A Case Report and Review of the Literature.

The West Indian medical journal·2015
Same author

Distribution of CXCR4 and γ-catenin expression pattern in breast cancer subtypes and their relationship to axillary nodal involvement.

Polish journal of pathology : official journal of the Polish Society of Pathologists·2013
Same journal

Dapagliflozin-induced anaphylactic shock.

Postgraduate medical journal·2026
Same journal

Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

Postgraduate medical journal·2026
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
See all related articles

Anthrax, a dangerous disease, gained notoriety after 2001 bioterrorism events. Its stable spores and limited human transmission make it a significant bioweapon threat.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biosecurity

Background:

  • Anthrax is a severe infectious disease caused by Bacillus anthracis.
  • The 2001 anthrax attacks in the US highlighted its potential for bioterrorism.
  • Key characteristics include high mortality, spore stability, and limited person-to-person transmission.

Purpose of the Study:

  • To underscore the threat posed by anthrax as a biological weapon.
  • To analyze the factors contributing to its potential misuse.
  • To inform biodefense and public health preparedness strategies.

Main Methods:

  • Review of historical anthrax incidents.
  • Analysis of Bacillus anthracis spore characteristics.
  • Assessment of transmission dynamics.

Related Experiment Videos

  • Evaluation of weaponization potential.

    • Main Results:

    • Anthrax spores are highly stable and environmentally persistent.
    • Limited human-to-human transmission reduces rapid spread but increases targeted impact.
    • The disease's high mortality rate is a significant factor in its threat profile.

    Conclusions:

    • Anthrax remains a credible bioterrorism threat due to its inherent properties.
    • Effective biodefense requires understanding its stability, transmission, and virulence.
    • Preparedness strategies must address the unique challenges of anthrax weaponization.